Humana SG&A decreased by 9.3% to $4.02B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.1%, from $3.38B to $4.02B. Over 3 years (FY 2021 to FY 2025), SG&A shows an upward trend with a 15.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Increases may indicate aggressive marketing or expansion, while decreases often reflect cost-cutting measures or improved corporate efficiency.
The sum of all direct and indirect selling expenses and all general and administrative expenses of a company. This inclu...
Used to assess the 'leaness' of a company's corporate structure relative to its peers.
selling_general_and_administrative| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.53B | $2.53B | $2.53B | $2.89B | $3.17B | $2.98B | $3.11B | $3.27B | $3.83B | $3.04B | $3.15B | $3.34B | $4.17B | $3.38B | $3.55B | $4.09B | $4.44B | $4.02B |
| QoQ Change | — | +0.0% | +0.0% | +14.1% | +9.9% | -6.1% | +4.4% | +5.1% | +17.0% | -20.5% | +3.5% | +6.1% | +24.8% | -18.9% | +4.9% | +15.2% | +8.6% | -9.3% |
| YoY Change | — | — | — | — | +25.4% | +3.2% | -2.0% | — | — | +2.1% | +1.2% | +2.1% | +8.9% | +11.1% | +12.7% | +22.3% | +6.5% | +19.1% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| CenterWell | $4.55B | $4.60B | $4.75B | $4.64B | $5.13B | $5.52B | $5.62B | $5.76B |
| Insurance | $2.40B | $2.60B | $3.09B | $2.53B | $2.56B | $2.81B | $3.36B | $2.78B |
| Total | $3.15B | $3.34B | $4.17B | $3.38B | $3.55B | $4.09B | $4.44B | $4.02B |